Sign In
Buy CDXS
$1.40
-0.0800 (-5.41%)
At Close: Jul 31, 2026
Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing
07:05am, Monday, 11'th Dec 2023
REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, hosted a virtual Key Opinion Leader (KOL) event on Friday, December 8, 2023,
3 Synthetic Biology Stocks Likely to Mint New Millionaires
02:46pm, Wednesday, 29'th Nov 2023
Synthetic biology refers to using engineered organisms to produce products for multiple industries. Specifically, the pharmaceutical, biotechnology, and agriculture sectors are set to benefit most fro
REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a virtual key opinion leader (KOL) event focuse
Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript
09:32pm, Thursday, 02'nd Nov 2023
Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
03:35pm, Friday, 27'th Oct 2023
REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic approac
Codexis to Report Third Quarter 2023 Financial Results on November 2
04:05pm, Thursday, 19'th Oct 2023
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third quar
Checking Out Codexis
02:11pm, Thursday, 05'th Oct 2023
Codexis, Inc. is undergoing a significant restructuring to reduce costs, refocus its developmental efforts and streamline its organization. The company's ECO platform to provide enzymes for RNA therap
The Next Nvidia: 3 AI Stocks That Could Break New Records
03:02pm, Saturday, 16'th Sep 2023
With artificial intelligence protocols requiring a ridiculous amount of computing capacity, the demand surge for graphics processing units (GPUs) naturally boosted Nvidia (NASDAQ: NVDA ) but it also l
Codexis to Participate in Cantor Global Healthcare Conference
04:05pm, Tuesday, 12'th Sep 2023
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare Confer
Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up
09:46am, Monday, 11'th Sep 2023
Codexis (CDXS) transfers the leasing rights of its San Carlos, CA location to Vaxcyte to focus on technology development, inducing cost savings, to extend its cash runway to mid-2026. The stock rises
Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now
08:50pm, Saturday, 08'th Jul 2023
The synthetic biology boom of the pandemic era has become a synthetic biology bust. Many synthetic biology stocks promised the moon and delivered mud.
Codexis to Report First Quarter 2023 Financial Results on May 4
04:05pm, Thursday, 20'th Apr 2023
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first qua
Codexis, Inc. (CDXS) Q4 2022 Earnings Call Transcript
10:23pm, Thursday, 23'rd Feb 2023
Codexis, Inc. (NASDAQ:CDXS ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Stephen Dilly - President, CEO & Director Kevin Norrett - COO Sriram Ryali - CFO Confere
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates
08:19pm, Thursday, 23'rd Feb 2023
Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23
04:05pm, Thursday, 09'th Feb 2023
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth qua
